What is the share price of Pfizer Ltd (PFIZER) today?
The share price of PFIZER as on 23rd April 2025 is ₹4243.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Pfizer Ltd (PFIZER) share?
The past returns of Pfizer Ltd (PFIZER) share are- Past 1 week: 1.18%
- Past 1 month: 3.01%
- Past 3 months: -11.31%
- Past 6 months: -22.87%
- Past 1 year: 2.21%
- Past 3 years: -2.41%
- Past 5 years: -3.98%
What are the peers or stocks similar to Pfizer Ltd (PFIZER)?
The peers or stocks similar to Pfizer Ltd (PFIZER) include:What is the dividend yield % of Pfizer Ltd (PFIZER) share?
The current dividend yield of Pfizer Ltd (PFIZER) is 0.82.What is the market cap of Pfizer Ltd (PFIZER) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Pfizer Ltd (PFIZER) is ₹19463.37 Cr as of 23rd April 2025.What is the 52 week high and low of Pfizer Ltd (PFIZER) share?
The 52-week high of Pfizer Ltd (PFIZER) is ₹6451.15 and the 52-week low is ₹3701.What is the PE and PB ratio of Pfizer Ltd (PFIZER) stock?
The P/E (price-to-earnings) ratio of Pfizer Ltd (PFIZER) is 35.30. The P/B (price-to-book) ratio is 5.41.Which sector does Pfizer Ltd (PFIZER) belong to?
Pfizer Ltd (PFIZER) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Pfizer Ltd (PFIZER) shares?
You can directly buy Pfizer Ltd (PFIZER) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Pfizer Ltd
PFIZER Share Price
4,243.500.26% (-11.00)
PFIZER Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PFIZER Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PFIZER Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 31.62 | 5.41 | 0.82% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.08 | 6.37 | 0.53% |
PFIZER Analyst Ratings & Forecast
Detailed Forecast 67%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
PFIZER Company Profile
Pfizer Limited is a pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas.
PFIZER Similar Stocks (Peers)
Compare with peersSUNPHARMA
PE Ratio
43.78
1Y Return
20.49%
Buy Reco %
88.24
CIPLA
PE Ratio
29.95
1Y Return
13.89%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
66.33
1Y Return
26.35%
Buy Reco %
68.00
MANKIND
PE Ratio
55.64
1Y Return
6.37%
Buy Reco %
81.25
DRREDDY
PE Ratio
17.53
1Y Return
0.37%
Buy Reco %
46.67
PFIZER Forecasts
Price
Revenue
Earnings
PFIZER Share Price Forecast
2024
Current
₹4,243.50
Baseline
Forecast for Apr 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹4,243.50
Baseline
Forecast for Apr 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
PFIZER Company Revenue Forecast
2024
Current
₹2.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2024
Current
₹2.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
PFIZER Stock EPS (Earnings Per Share) Forecast
2024
Current
₹120.50
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹120.50
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
PFIZER
Income
Balance Sheet
Cash Flow
Annual Normal View
PFIZER Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,109.22 | 2,197.85 | 2,082.80 | 2,248.89 | 2,335.67 | 2,319.67 | 2,673.64 | 2,558.81 | 2,381.63 | 2,438.87 | ||||||||||
Raw Materials | 735.20 | 812.24 | 712.17 | 838.78 | 829.02 | 783.39 | 1,020.93 | 817.19 | 804.39 | 1,533.91 | ||||||||||
| Power & Fuel Cost | 10.43 | 10.34 | 12.34 | 11.45 | 11.04 | 5.79 | 5.67 | 6.51 | 3.98 | |||||||||||
| Employee Cost | 277.34 | 303.89 | 314.29 | 323.84 | 364.51 | 361.06 | 403.67 | 331.68 | 347.80 | |||||||||||
| Selling & Administrative Expenses | 375.97 | 383.12 | 316.73 | 335.32 | 319.66 | 268.67 | 310.77 | 298.03 | 317.96 | |||||||||||
| Operating & Other expenses | 180.53 | 106.54 | 112.34 | 6.48 | 54.70 | 107.24 | 34.01 | 162.40 | 83.72 | |||||||||||
EBITDA | 529.75 | 581.72 | 614.93 | 733.02 | 756.74 | 793.52 | 898.59 | 943.00 | 823.78 | 904.96 | ||||||||||
| Depreciation/Amortization | 57.93 | 62.93 | 66.25 | 71.39 | 103.24 | 109.41 | 115.00 | 105.51 | 62.28 | 58.14 | ||||||||||
| PBIT | 471.82 | 518.79 | 548.68 | 661.63 | 653.50 | 684.11 | 783.59 | 837.49 | 761.50 | 846.82 | ||||||||||
| Interest & Other Items | 1.40 | 1.96 | 0.77 | 1.72 | 11.01 | 15.39 | 10.70 | 13.48 | 15.43 | 12.67 | ||||||||||
| PBT | 470.42 | 516.83 | 547.91 | 659.91 | 642.49 | 668.72 | 772.89 | 824.01 | 746.07 | 834.15 | ||||||||||
| Taxes & Other Items | 165.44 | 180.05 | 187.84 | 230.86 | 133.36 | 171.11 | 160.33 | 200.08 | 194.74 | 218.63 | ||||||||||
| Net Income | 304.98 | 336.78 | 360.07 | 429.05 | 509.13 | 497.61 | 612.56 | 623.93 | 551.33 | 615.52 | ||||||||||
| EPS | 66.66 | 73.61 | 78.70 | 93.78 | 111.28 | 108.76 | 133.88 | 136.37 | 120.50 | 134.53 | ||||||||||
| DPS | 15.00 | 20.00 | 20.00 | 22.50 | 330.00 | 35.00 | 35.00 | 70.00 | 35.00 | 35.00 | ||||||||||
| Payout ratio | 0.23 | 0.27 | 0.25 | 0.24 | 2.97 | 0.32 | 0.26 | 0.51 | 0.29 | 0.26 |
PFIZER Company Updates
FY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFPFIZER Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Pfizer Ltd | 35.30 | 5.41 | 0.82% |
| Sun Pharmaceutical Industries Ltd | 43.78 | 6.25 | 0.77% |
| Cipla Ltd | 29.95 | 4.60 | 0.85% |
| Torrent Pharmaceuticals Ltd | 66.33 | 16.03 | 0.86% |
PFIZER Stock Price Comparison
Compare PFIZER with any stock or ETFCompare PFIZER with any stock or ETF
PFIZER
PFIZER Shareholdings
PFIZER Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
PFIZER Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
PFIZER Shareholding Pattern
PFIZER Shareholding History
Foreign Institutions
Mutual Funds Invested in PFIZER
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Pfizer Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4813% | Percentage of the fund’s portfolio invested in the stock 0.87% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/244 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.8003% | Percentage of the fund’s portfolio invested in the stock 1.41% | Change in the portfolio weight of the stock over the last 3 months -0.33% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/106 (+36) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.8323% | Percentage of the fund’s portfolio invested in the stock 2.33% | Change in the portfolio weight of the stock over the last 3 months -0.29% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/46 (-7) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing PFIZER stock
Looks like this stock is not in any smallcase yet.
PFIZER Events
PFIZER Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.82%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹8.23 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PFIZER Upcoming Dividends
No upcoming dividends are available
PFIZER Past Dividends
Cash Dividend
Ex DateEx DateAug 21, 2024
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Aug 21, 2024
Cash Dividend
Ex DateEx DateAug 11, 2023
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 11, 2023
Special
Special | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Special
Special | Div/Share: ₹30.00
Dividend/Share
₹30.00
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateAug 18, 2022
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Aug 18, 2022
PFIZER Stock News & Opinions
Articles & Videos
Spotlight
Volumes spurt at Pfizer Ltd counter
Triveni Engineering and Industries Ltd, Century Plyboards (India) Ltd, 360 ONE WAM Ltd, Data Patterns (India) Ltd are among the other stocks to see a surge in volumes on NSE today, 24 February 2025.Pfizer Ltd notched up volume of 9.3 lakh shares by 14:14 IST on NSE, a 18.12 fold spurt over two-week average daily volume of 51359 shares. The stock rose 5.50% to Rs.4,320.35. Volumes stood at 16716 shares in the last session.Triveni Engineering and Industries Ltd notched up volume of 23.57 lakh shares by 14:14 IST on NSE, a 6.64 fold spurt over two-week average daily volume of 3.55 lakh shares. The stock rose 1.89% to Rs.385.00. Volumes stood at 4.36 lakh shares in the last session.Century Plyboards (India) Ltd notched up volume of 26.98 lakh shares by 14:14 IST on NSE, a 4.54 fold spurt over two-week average daily volume of 5.95 lakh shares. The stock slipped 0.03% to Rs.771.20. Volumes stood at 37.38 lakh shares in the last session.360 ONE WAM Ltd recorded volume of 23.65 lakh shares by 14:14 IST on NSE, a 3.83 times surge over two-week average daily volume of 6.18 lakh shares. The stock gained 4.84% to Rs.1,028.70. Volumes stood at 4.82 lakh shares in the last session.Data Patterns (India) Ltd notched up volume of 24.05 lakh shares by 14:14 IST on NSE, a 3.2 fold spurt over two-week average daily volume of 7.52 lakh shares. The stock rose 4.43% to Rs.1,622.50. Volumes stood at 9.46 lakh shares in the last session.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Volumes spurt at Pfizer Ltd counter
Century Plyboards (India) Ltd, L&T Technology Services Ltd, Tata Consultancy Services Ltd, AAVAS Financiers Ltd are among the other stocks to see a surge in volumes on BSE today, 24 February 2025.Pfizer Ltd registered volume of 14873 shares by 10:48 IST on BSE, a 6.97 fold spurt over two-week average daily volume of 2134 shares. The stock rose 6.73% to Rs.4,370.00. Volumes stood at 1532 shares in the last session.Century Plyboards (India) Ltd recorded volume of 36095 shares by 10:48 IST on BSE, a 1.86 times surge over two-week average daily volume of 19370 shares. The stock gained 4.61% to Rs.806.15. Volumes stood at 1.32 lakh shares in the last session.L&T Technology Services Ltd notched up volume of 6418 shares by 10:48 IST on BSE, a 1.79 fold spurt over two-week average daily volume of 3576 shares. The stock slipped 5.44% to Rs.4,841.90. Volumes stood at 5194 shares in the last session.Tata Consultancy Services Ltd clocked volume of 1.44 lakh shares by 10:48 IST on BSE, a 1.72 times surge over two-week average daily volume of 83609 shares. The stock lost 1.77% to Rs.3,718.70. Volumes stood at 89843 shares in the last session.AAVAS Financiers Ltd recorded volume of 5714 shares by 10:48 IST on BSE, a 1.61 times surge over two-week average daily volume of 3552 shares. The stock lost 0.45% to Rs.1,683.25. Volumes stood at 3418 shares in the last session.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Pfizer partners with Mylan for Marketing of Ativan and Pacitane
The agreement is for a period of five years and applies within the territory of India. Mylan has a strong presence in the Central Nervous System (CNS) therapy area, supported by skilled resources that engage with super specialists such as neurologists and psychiatrists. This collaboration with Mylan will enhance the distribution and in-clinic presence of Pfizer's products. Pfizer is involved in the manufacturing, marketing, trading, and export of pharmaceutical products. The pharma company's net profit rose 2.8% to Rs 127.60 crore in Q3 FY25 as against Rs 124.11 crore recorded in Q3 FY24. Revenue from operations shed 0.4% year on year to Rs 537.99 crore during the quarter. Shares of Pfizer shed 0.41% to Rs 4,095.55 on the BSE.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Pfizer announces cessation of director
Pfizer announced that Sunil Lalbhai has completed his second term as an Independent Director of the Company with effect from the end of the day on 13 February 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Pfizer standalone net profit declines 1.83% in the December 2024 quarter
Net profit of Pfizer declined 1.83% to Rs 127.60 crore in the quarter ended December 2024 as against Rs 129.98 crore during the previous quarter ended December 2023. Sales declined 0.37% to Rs 537.99 crore in the quarter ended December 2024 as against Rs 539.97 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales537.99539.97 0 OPM %27.1428.25 - PBDT187.24185.54 1 PBT172.44167.99 3 NP127.60129.98 -2 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Pfizer to discuss results
Pfizer will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Pfizer announces cessation of directors
Pfizer announced that Pradip Shah and Uday Khanna, have completed their term as Independent Directors of the Company with effect from the end of the day on 09 November 2024. Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Pfizer standalone net profit rises 6.30% in the September 2024 quarter
Net profit of Pfizer rose 6.30% to Rs 158.35 crore in the quarter ended September 2024 as against Rs 148.96 crore during the previous quarter ended September 2023. Sales rose 2.33% to Rs 588.59 crore in the quarter ended September 2024 as against Rs 575.21 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales588.59575.21 2 OPM %32.1531.75 - PBDT230.22215.95 7 PBT215.23200.52 7 NP158.35148.96 6 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Pfizer announces board meeting date
Pfizer will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Pfizer to hold AGM
Pfizer announced that the Annual General Meeting (AGM) of the company will be held on 28 August 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 1.15%, vs industry avg of 9.04%
Over the last 5 years, market share decreased from 1.02% to 0.62%
Over the last 5 years, net income has grown at a yearly rate of 5.14%, vs industry avg of 15.28%